Enhancing compliance in schizophrenic patients by weekly dosing with levothyroxine sodium.
Walch
T J
TJ
D000328:Adult; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D015897:Comorbidity; D004334:Drug Administration Schedule; D006801:Humans; D007037:Hypothyroidism / Q000188:drug therapy* / Q000453:epidemiology; D007902:Length of Stay; D008297:Male; D010349:Patient Compliance; D012559:Schizophrenia / Q000188:drug therapy* / Q000453:epidemiology; D013974:Thyroxine / Q000008:administration & dosage*
D014150:Antipsychotic Agents; D013974:Thyroxine